SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001437749-23-024727
Filing Date
2023-08-28
Accepted
2023-08-25 19:34:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D zfe20230825_sc13d.htm SC 13D 45838
  Complete submission text file 0001437749-23-024727.txt   47413
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02216
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02216 (617) 744-4400
CervoMed Inc. (Subject) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-54715 | Film No.: 231209786
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PUMA BIOTECHNOLOGY INC. 10880 WILSHIRE BOULEVARD, SUITE 2150 LOS ANGELES CA 90024
Business Address
ZAVRL FRANK (Filed by) CIK: 0001652169 (see all company filings)

Type: SC 13D